13F

Stock

Intensity Therapeutics, Inc.

INTS · held by 12 managers

Reported value

$829.5K

Holders

12

+10 new · −0 exited

Holders’ est. mark

$491.6K

Price effect on 7 books still in the name

Largest holder

$153K

GEODE CAPITAL MANAGEMENT, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC26K$153K$142.3KCut−$35.8K
SAPIENT CAPITAL LLC26K$152.9K$143.1KCut−$91.3K
NANO CAP NEW MILLENNIUM GROWTH FUND L P25K$147KNew
Rothschild Wealth LLC23.3K$137K$127.4KCut−$66.5K
VANGUARD CAPITAL MANAGEMENT LLC16.8K$99KHeld
Mesirow Financial Investment Management, Inc.14.1K$83K$77.2KCut−$19.9K
VANGUARD FIDUCIARY TRUST CO9.12K$53.6KHeld
WELLS FARGO & COMPANY/MN200$1.18KNew
OSAIC HOLDINGS, INC.200$1.18KNew
UBS Group AG192$1.13K$1.05KCut−$9.28K
Tower Research Capital LLC (TRC)67$394$367Cut−$8.44K
MORGAN STANLEY20$118$110Cut−$87

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.